A couple is using their sequencing results to guide their healthcare, diet, and more.
France is to invest €670 million in personalized medicine centers, according to RFI.
In Nature this week: maximum-depth sequencing to detect rare variants, and more.
The FDA has just approved the first clinical trial for a DNA-based vaccine for the Zika virus, Technology Review reports.
A federal safety panel gives the go-ahead to a study that plans to use CRISPR to alter patients' immune cells to treat their cancer.
Researchers find that certain genes have increased expression after death, New Scientist reports.
In Genome Research this week: a tool to assess the quality of de novo transcriptome assemblies, characterizing genes in the soil amoeba Dictyostelium discoideum, and more.
Nature highlights a crop of Chinese researchers, including a geneticist focusing on ancient DNA and a plant biologist applying genome editing.
Officials from federal agencies and some lawmakers say a proposal to increase set-asides for research at small businesses would take away from basic research.
Technology Review's Antonio Regalado takes a look at 23andMe's data-selling business.
In PNAS this week: genetic evidence of sympatric speciation in blind mole rats, Tibetan population history, and more.
Most researchers in the UK oppose leaving the European Union, Technology Review reports.
Genetic evidence of a break in the paternal line a few generations back bolsters a rival claim to a Scottish baronetcy, the Guardian reports.
Business Insider includes Illumina's Jay Flatley on its list of creators.
In PLOS this week: approach for finding genes involved in oncogenesis, new adenovirus species found in penguins, and more.
A safety panel is to review a proposal next week to use CRISPR as part of a cancer treatment, Technology Review reports.
US Department of Energy supercomputers will help power the Cancer Moonshot initiative, Stat News reports.
A psychologist finds that having a certain number of women already in a STEM field might help recruit even more, NPR reports.
In Science this week: RNA-based therapies, biomarkers in precision medicine, and more.
In a Scientific American blog post, Skip Garner calls on researchers to finish that last 1 percent of the human genome.
New gene therapies are promising, but also pricey, Nature News writes.
Senators point to critical GAO reports on FDA as reason to take up the 21st Century Cures Act, Stat News reports.
In Nature this week: effect of genetic diversity on the proteome and sequence of virus linked to panda deaths.
At PLOS Biology, researchers urge their colleagues to authenticate the cell lines they use.
To beef up clinical trial numbers, Strata Oncology has said it will give free genetic testing to 100,000 cancer patients.
The US National Labor Relations Board rules that graduate assistants have the right to unionize.
Sociologists find that dual-career programs are important for recruiting female academics, Inside Higher Ed reports.
Many more PhDs are produced in the sciences than there are tenure-track professor positions, the New York Times reports.
The Huffington Post explores why female graduate students might not report sexual harassment.